There are many biomarkers for LN, such as antiphospholipid antibody, urinary neutrophil gelatinase-associated lipid carrier protein, urinary CD163, etc, but most of these biomarkers are related to diagnosis or therapeutic response. The gene discussed is CD163; the disease is lobular neoplasia.